Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluidized bed adsorbent systems for extracorporeal liver support.

Dieter Falkenhagen1, Martin Brandl, Jens Hartmann

  • 1Center for Biomedical Technology & Christian Doppler Laboratory for Specific Adsorption Technologies in Medicine, Danube University Krems, Krems, Austria. dieter.falkenhagen@donau-uvi.ac.at

Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
|May 11, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dextran sulfate restores endotoxin detectability in human serum.

Analytical and bioanalytical chemistry·2026
Same author

Extracellular Vesicles in Hemostasis.

Clinics in laboratory medicine·2026
Same author

Oral bioavailability of fenofibrate from melt-extruded phospholipid-containing solid dispersions: A rat study.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same author

Mesenchymal Stromal Cells Respond to SARS-CoV-2 Peptides and Exhibit Altered T-Cell Regulatory Capacity.

Cells·2026
Same author

Dissolution-microdialysis predicts oral bioavailability from phospholipid-based amorphous solid dispersions.

Journal of pharmaceutical sciences·2026
Same author

Microdialysis during in vitro lipolysis explains enhanced permeation of indomethacin from phospholipid-based amorphous solid dispersions.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026

A novel microsphere-based detoxification system (MDS) effectively removes toxins in acute liver failure. This innovative technology shows promise for clinical application in improving liver function and patient outcomes.

Area of Science:

  • Hepatology
  • Biomedical Engineering
  • Toxicology

Background:

  • Acute liver failure (ALF) and acute-on-chronic liver failure (AoCLF) present complex challenges due to severe liver dysfunction.
  • Detoxification is critical for managing ALF, necessitating efficient artificial liver support systems.
  • Existing systems require enhancement for broader toxin removal capabilities.

Purpose of the Study:

  • To introduce and evaluate a novel microsphere-based detoxification system (MDS) for acute liver failure.
  • To assess the efficacy of MDS in adsorbing various toxins, including albumin-bound and non-protein-bound substances.
  • To demonstrate the safety and potential of MDS for clinical application.

Main Methods:

  • Development of a microsphere-based detoxification system (MDS) using microadsorbents (1-10 microm) in suspension.

Related Experiment Videos

  • In vitro testing of MDS with a combination of hydrophobic neutral resin and anion exchange resin.
  • Incorporation of fluorescently labeled magnetic microparticles for safety monitoring via an optical system with a magnetic trap.
  • Evaluation of toxin elimination kinetics for albumin-bound (bilirubin, cholic acid) and non-protein-bound (phenol) substances.
  • Assessment of inflammatory mediator removal (e.g., TNF-alpha) using specific adsorbents with plasma or Albuflow filters.

    • Main Results:

    • MDS demonstrated excellent adsorption capacity and elimination kinetics for both albumin-bound and non-protein-bound toxins.
    • The system effectively removed unconjugated bilirubin, cholic acid, and phenol in vitro.
    • Safety was ensured through magnetic microparticle detection, preventing leakage into the blood circuit.
    • The technology allows for the removal of inflammatory mediators like TNF-alpha when specific adsorbents are used.

    Conclusions:

    • The microsphere-based detoxification system (MDS) is a highly efficient technology for managing acute liver failure.
    • MDS shows significant potential for clinical application due to its broad toxin adsorption capabilities and safety features.
    • This innovative approach offers a promising advancement in artificial liver support systems for detoxification.